Safety of Administering Isoniazid to SLE Patients to Prevent TB

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Tuberculosis · Systemic Lupus Erythematosus

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Rumah Sakit Dr Hasan Sadikin, Universitas Padjadjaran, Bandung, West Java, Indonesia
Contact: Study coordinator (Laniyati Hamijoyo) · laniyati.hamijoyo@unpad.ac.id · 62222040151

Study leads

Laniyati Hamijoyo, MD, PhD
Principal Investigator
Universitas Padjadjaran

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Phase I Study Investigating the Local Tolerability and Pharmacokinetics of Isoniazid (INH) Inhalation by Wet Nebulization in Patients With Tuberculosis

Tuberculosis

Abroad (travel likely)RecruitingPHASE1

Groningen, Netherlands

Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis

Tuberculosis · Acute Coronary Syndrome · Pulmonary Hypertension (Diagnosis)

Abroad (travel likely)RecruitingPHASE3

Kota Kinabalu, Malaysia · Kota Kinabalu, Malaysia

Optimizing(O) RIfapentine-based(RI) Regimen and shortENing(EN) the Treatment of Drug-sensitive Tuberculosis(T)

Tuberculosis, Pulmonary

Abroad (travel likely)RecruitingPHASE2, PHASE3

Guiyang, China · Kaili, China

Sorfequiline-based Regimens in Adults With Newly Diagnosed Drug-sensitive Pulmonary TB

Tuberculosis, Pulmonary

Abroad (travel likely)RecruitingPHASE2

Port Elizabeth, South Africa · Pretoria, South Africa